Department of Psychiatry

September 5, 2017

Pain and Alzheimer’s disease

Clinicians should use a structured interview in people with Alzheimer’s disease to identify pain that might be otherwise overlooked.

By VUMC News and Communications
April 28, 2017

Regulating anxiety in the brain

Two brain signaling pathways have overlapping functions in regulating anxiety, suggesting that therapeutics aimed at one or the other will impact both.

By Leigh MacMillan
March 28, 2017

Vanderbilt study finds natural chemical helps brain adapt to stress

A natural signaling molecule that activates cannabinoid receptors in the brain plays a critical role in stress-resilience — the ability to adapt to repeated and acute exposures to traumatic stress, according to researchers at Vanderbilt University Medical Center.

By Bill Snyder
March 2, 2017

Clues found to recurrent depression

Women who have had repeated depressive episodes tend to pay more attention to negative emotional information, suggesting that they may benefit from cognitive therapy to build new, more positive pathways in their brains.

By Bill Snyder
November 4, 2016

Probing drug abuse circuitry

Vanderbilt researchers have identified cocaine-induced modifications at specific neuronal connections, which could aid the development of new therapies for substance abuse disorders.

By Leigh MacMillan
child hiding behind a corner
October 13, 2016

Study may help predict anxiety risk in children

In what could be a way to predict which children might be vulnerable to anxiety disorders, a Vanderbilt study has shown that an altered prefrontal cortex function in the brain marks a heightened anxiety risk in children.

By Nancy Humphrey
July 28, 2016

Opioids’ impact on women’s health explored at research symposium

Women may be at higher risk than men when it comes to overuse of opioid-containing painkillers, speakers warned at a research symposium at Vanderbilt University Medical Center earlier this month.
By Bill Snyder
July 18, 2016

Diabetes drugs may ease addiction

Drugs that are being used clinically to treat obesity and diabetes may also have a role in treating drug abuse.
By Bill Snyder
June 2, 2016

Alzheimer’s risk gene in younger adults

A genetic risk factor for Alzheimer’s disease in later life appears to benefit younger adults as they age.
By Leigh MacMillan
May 12, 2016

COX-2 blocker could help PTSD

COX-2 inhibitors – used clinically to reduce inflammation and pain – may find new applications for treating PTSD and other stress-related psychiatric disorders like major depression.
By Bill Snyder
February 19, 2016

School of Medicine’s Patel receives Presidential Early Career Award

Vanderbilt University Medical Center’s Sachin Patel, associate professor of Psychiatry and of Molecular Physiology and Biophysics, is one of 106 researchers named today by President Obama as a recipient of the Presidential Early Career Award for Scientists and Engineers, the highest honor bestowed by the United States government on science and engineering professionals in the early stages of their independent research careers.
By Craig Boerner
February 19, 2016

Face recognition and social anxiety

An inability to recognize faces may be an important mechanism underlying social inhibition and may contribute to, or maintain, social anxiety.
By Sanjay Mishra
February 5, 2016

Trivedi named CEO of Vanderbilt Psychiatric Hospital

Harsh Trivedi, M.D., MBA, associate professor of Psychiatry, vice chair for Clinical Affairs for Vanderbilt’s Department of Psychiatry, and executive director and chief medical officer of Vanderbilt Behavioral Health, has been named CEO of Vanderbilt Psychiatric Hospital. He will remain administrative director for Vanderbilt Behavioral Health.
By Nancy Humphrey
1 … 4 5 6 7 8 9